Medicine News and Research

RSS

Itamar Medical, Roche enter development agreement for EndoPAT device

Itamar Medical, the leader in non-invasive vascular health diagnostics, announced today that an agreement has been signed with Roche by which Itamar will develop an EndoPAT device designated for use with animal models, enabling pre-clinical studies examining the efficacy of various compounds in the early stage of drug development essential for later stage development in humans.

20 Dec 2010

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Arrowhead Research Corporation today announced that it has executed an exclusive world-wide license on technology developed by Drs. Wadih Arap and Renata Pasqualini at MD Anderson Cancer Center for use in weight loss and obesity-related metabolic conditions, and that it has launched a new company, Ablaris Therapeutics Inc., to commercialize this platform.

20 Dec 2010

MEDNAX acquires Neonatology Associates in Kingsport

MEDNAX, Inc., today announced the acquisition of a neonatal physician group based in Kingsport, TN.

20 Dec 2010

AHF calls on Sen. Nelson to address Florida's AIDS drug crisis

On Monday, December 20 at 6:00 PM, AIDS Healthcare Foundation (AHF) will host a town hall and public forum at the African Heritage Cultural Arts Center calling on U.S. Senator Bill Nelson to immediately address Florida's AIDS drug crisis which has left nearly 2,400 patients without access to lifesaving AIDS medications. Town hall attendees will include AIDS advocates, patients, healthcare professionals, community leaders and concerned citizens.

20 Dec 2010

Exciting progress made in MS research during 2010

Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra).

20 Dec 2010

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

With value-based purchasing (VBP) now law under health reform, hospitals participating in the nation's largest hospital VBP demonstration are providing lessons learned that can help others save lives and better craft rules to govern the new program.

20 Dec 2010

Health Care at Home: Trends and issues

Leaders in the nation's Health Care at Home movement outlined trends and issues during a webinar for physicians across the country today. The webinar, "Why Health Care is Going Home," offered industry insights and detailed the reasons why home care will play a major role in the future of health care in America.

20 Dec 2010

Take charge of your medical tests

Whether you're healthy or ill, there are a variety of medical tests your health care team might recommend for you. A yearly checkup often includes routine tests such as blood sugar and cholesterol levels, vision and hearing assessments, tests for heart functioning and others used to monitor a chronic condition—such as a lung function test for those with asthma.

20 Dec 2010

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

SEEK, a leading UK privately-owned drug-discovery group, is pleased to announce the establishment of a new joint venture entity with Pernix Therapeutics Holdings, an integrated specialty pharmaceutical company focused primarily on the United States pediatric market.

20 Dec 2010

FVCG invests $175,000 in Celvive for stem cell research in spinal cord injury

Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options. In the United States alone, there are more than 250,000 people living with SCI; approximately three million worldwide are affected.

20 Dec 2010

Cardio3 BioSciences presents positive C3BS-GQR-1 results in patients with acute myocardial infarction

Cardio3 BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces positive pre-clinical results from its in-house product candidate C3BS-GQR-1, to treat patients suffering from acute myocardial infarction in order to protect cardiac tissue from damage and direct heart stem cells to mature and restore pump function.

20 Dec 2010

FDA moves to curb Avastin's approval for breast cancer

The Food and Drug administration on Thursday revoked its approval of Roche drug Avastin for the treatment of breast cancer. The agency's action, based on findings that did not confirm that the medicine helped patients with this disease, has drawn criticism from patients and politicians.

20 Dec 2010

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

Inspire Pharmaceuticals, Inc. announced today that the results from its first Phase 3 clinical trial with denufosol tetrasodium for cystic fibrosis (CF), TIGER-1, have been published in the peer-reviewed publication, American Journal of Respiratory and Critical Care Medicine (AJRCCM). Denufosol is an investigational, inhaled, novel ion channel regulator currently in Phase 3 clinical development for the treatment of CF.

20 Dec 2010

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

Sanofi-aventis US and Oxford University have entered into an agreement to conduct multi-phase oncology clinical and epidemiological research with INDOX, India's leading academic oncology network.

20 Dec 2010

Researchers examine socio-economic consequences of hypersomnia

Danish sleep researchers at the University of Copenhagen and the Danish Institute for Health Services Research have examined the socio-economic consequences of the sleep disorder hypersomnia in one of the largest studies of its kind.

20 Dec 2010

SAGE publishes first comprehensive textbook on psychology

Psychology for medicine, published today by SAGE, is the first comprehensive textbook on psychology for medical students that is relevant to all of their undergraduate studies.

20 Dec 2010

Scientists suggest targeting ion channels could offer effective pain relief

University at Buffalo neuroscience researchers conducting basic research on ion channels have demonstrated a process that could have a profound therapeutic impact on pain.

20 Dec 2010

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

New research into the health benefits of beetroot juice suggests it's not only athletes who can benefit from its performance enhancing properties - its physiological effects could help the elderly or people with heart or lung-conditions enjoy more active lives.

20 Dec 2010

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

Cystic fibrosis patients with normal to mildly impaired lung function may benefit from a new investigational drug designed to help prevent formation of the sticky mucus that is a hallmark of the disease, according to researchers involved in a phase 3 clinical trial of the drug.

19 Dec 2010

Completely fearless woman stirs scientific interest

It has been known since the 1930s that when a certain part of monkeys’ brains were removed, the animals became fearless. Now similar effects are being seen in humans according to a study in the journal Current Biology. Justin Feinstein, the study’s lead author and a clinical neuropsychologist at the University of Iowa said, “There’s not very many humans with this sort of brain damage… Luckily for us, we had access to a patient, SM, and we studied her different fear behaviours and we read her personal diaries.”

19 Dec 2010

Medicine News and Research

Itamar Medical, Roche enter development agreement for EndoPAT device

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

MEDNAX acquires Neonatology Associates in Kingsport

AHF calls on Sen. Nelson to address Florida's AIDS drug crisis

Exciting progress made in MS research during 2010

Participants in CMS, Premier healthcare alliance HQID VBP project raise quality by 18.3%

Health Care at Home: Trends and issues

Take charge of your medical tests

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

FVCG invests $175,000 in Celvive for stem cell research in spinal cord injury

Cardio3 BioSciences presents positive C3BS-GQR-1 results in patients with acute myocardial infarction

FDA moves to curb Avastin's approval for breast cancer

Inspire's denufosol tetrasodium TIGER-1 Phase 3 trial for CF published in AJRCCM

Sanofi-aventis, Oxford University to conduct multi-phase oncology research in India

Researchers examine socio-economic consequences of hypersomnia

SAGE publishes first comprehensive textbook on psychology

Scientists suggest targeting ion channels could offer effective pain relief

Research: Beetroot juice may allow patients with heart and lung-conditions to enjoy more active lives

CF patients with normal to mildly impaired lung function may benefit from new investigational drug

Completely fearless woman stirs scientific interest

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News